Genomic analysis can vastly enhance drug safety by identifying genetic factors that influence drug metabolism and toxicity. By understanding these genetic variations, pharmaceutical companies can develop drugs with fewer adverse effects and tailor treatments to individual genetic profiles, a concept known as personalized medicine. This approach not only improves treatment efficacy but also minimizes the risk of adverse drug reactions, a significant concern in the field of pharmacogenomics.
